Acorda Therapeutics, Inc. Proceeds from Convertible Debt
Acorda Therapeutics, Inc. reported Proceeds from Convertible Debt of $345.00 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2017-02-27
- Acorda Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2014-12-31 was $0.00.
- Acorda Therapeutics, Inc. proceeds from convertible debt for the quarter ending 2014-09-30 was $0.00.
- Acorda Therapeutics, Inc. proceeds from convertible debt for fiscal 2014 was $345.00M.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 6 month | Proceeds from Convertible Debt 9 month | Proceeds from Convertible Debt 12 month |
|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $0.00 derived: sum of 2 quarters · filed 2017-02-27 | $345.00M 10-K · filed 2017-02-27 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $345.00M 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $345.00M 10-Q · filed 2015-08-07 |